153 related articles for article (PubMed ID: 7537917)
1. A novel mechanism for exposure of fibrinogen binding sites on GPIIb-IIIa by a monoclonal antibody.
Hato T; Watanabe A; Nakatani S; Minamoto Y; Fujita S
Thromb Haemost; 1995 Jan; 73(1):138-43. PubMed ID: 7537917
[TBL] [Abstract][Full Text] [Related]
2. Exposure of platelet fibrinogen receptors by a monoclonal antibody to the GPIIb-IIIa complex, PMA4.
Watanabe A; Hato T; Kobayashi Y
Int J Hematol; 1992 Aug; 56(1):79-87. PubMed ID: 1382664
[TBL] [Abstract][Full Text] [Related]
3. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
[TBL] [Abstract][Full Text] [Related]
4. [Inhibition of thrombocyte aggregation by F(ab')2-fragments of monoclonal antibodies FraMon (CRC64) to glycoproteins IIb-IIIa].
Mazurov AV; Pevzner DV; Khaspekova SG; Dudnik OA; Byzova TV; Vlasik TN; Bakharev VN; Pistsov MIu; Staroverov II; Ruda MIa
Ter Arkh; 2001; 73(9):66-73. PubMed ID: 11642086
[TBL] [Abstract][Full Text] [Related]
5. Partial inhibition of platelet aggregation and fibrinogen binding by a murine monoclonal antibody to GPIIIa: requirement for antibody bivalency.
Kutok JL; Coller BS
Thromb Haemost; 1994 Dec; 72(6):964-72. PubMed ID: 7537915
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody to the human platelet glycoprotein IIb/IIIa complex induces platelet activation.
Modderman PW; Huisman HG; van Mourik JA; von dem Borne AE
Thromb Haemost; 1988 Aug; 60(1):68-74. PubMed ID: 2973154
[TBL] [Abstract][Full Text] [Related]
7. A humanized antibody specific for the platelet integrin gpIIb/IIIa.
Co MS; Yano S; Hsu RK; Landolfi NF; Vasquez M; Cole M; Tso JT; Bringman T; Laird W; Hudson D
J Immunol; 1994 Mar; 152(6):2968-76. PubMed ID: 8144896
[TBL] [Abstract][Full Text] [Related]
8. Natural antibodies against the immunoglobulin F(ab')2 fragment cause elimination of antigens recognized by the F(ab')2 from the circulation.
Yano S; Kaku S; Suzuki K; Terazaki C; Sakayori T; Kawasaki T; Kawamura K; Sugita Y; Hoshino K; Masuho Y
Eur J Immunol; 1995 Nov; 25(11):3128-33. PubMed ID: 7489753
[TBL] [Abstract][Full Text] [Related]
9. Characterization of human platelet IgG Fc receptor associated with membrane glycoprotein.
Shido K; Ahmad G; Hsu L; Kamiyama M
J Clin Lab Immunol; 1995; 46(1):1-11. PubMed ID: 9363587
[TBL] [Abstract][Full Text] [Related]
10. Clues for understanding the structure and function of a prototypic human integrin: the platelet glycoprotein IIb/IIIa complex.
Calvete JJ
Thromb Haemost; 1994 Jul; 72(1):1-15. PubMed ID: 7974356
[TBL] [Abstract][Full Text] [Related]
11. [Identification of human platelet specific functional antibody and its fragments].
Chu XX; Hou M; Zhu YY; Peng J; Ji XB; Zhang F; Wang L
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3464-8. PubMed ID: 16686061
[TBL] [Abstract][Full Text] [Related]
12. Effects of IgG and its F(ab')2 fragments of some patients with idiopathic thrombocytopenic purpura on platelet aggregation.
Chu XX; Hou M; Peng J; Zhu YY; Ji XB; Wang L; Zhang F; Ma DX
Eur J Haematol; 2006 Feb; 76(2):153-9. PubMed ID: 16405437
[TBL] [Abstract][Full Text] [Related]
13. Stabilization of platelet-fibrinogen interactions is an integral property of the glycoprotein IIb-IIIa complex.
Peerschke EI
J Lab Clin Med; 1994 Sep; 124(3):439-46. PubMed ID: 8083588
[TBL] [Abstract][Full Text] [Related]
14. Absence of ligands bound to glycoprotein IIB-IIIA on the exposed surface of a thrombus may limit thrombus growth in flowing blood.
Heynen HF; Lozano Molero M; de Groot PG; Nieuwenhuis HK; Sixma JJ
J Clin Invest; 1994 Sep; 94(3):1098-112. PubMed ID: 8083351
[TBL] [Abstract][Full Text] [Related]
15. Targeting ligand-induced binding sites on GPIIb/IIIa via single-chain antibody allows effective anticoagulation without bleeding time prolongation.
Stoll P; Bassler N; Hagemeyer CE; Eisenhardt SU; Chen YC; Schmidt R; Schwarz M; Ahrens I; Katagiri Y; Pannen B; Bode C; Peter K
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1206-12. PubMed ID: 17322097
[TBL] [Abstract][Full Text] [Related]
16. Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets.
Wagner CL; Mascelli MA; Neblock DS; Weisman HF; Coller BS; Jordan RE
Blood; 1996 Aug; 88(3):907-14. PubMed ID: 8704248
[TBL] [Abstract][Full Text] [Related]
17. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding.
Kleinschnitz C; Pozgajova M; Pham M; Bendszus M; Nieswandt B; Stoll G
Circulation; 2007 May; 115(17):2323-30. PubMed ID: 17438148
[TBL] [Abstract][Full Text] [Related]
18. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.
Tornai I; Arnout J; Deckmyn H; Peerlinck K; Vermylen J
J Clin Invest; 1993 Jan; 91(1):273-82. PubMed ID: 8423224
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of antibodies that bind GPIIb/IIIa: antagonist complexes.
Breth L; Kochie J; Combs A; Wang S; Smallheer J; Billheimer J; Seiffert D; Hollis G; O'Neil K
J Immunol Methods; 2005 Jun; 301(1-2):11-20. PubMed ID: 15992818
[TBL] [Abstract][Full Text] [Related]
20. The Arg-Gly-Asp (RGD) recognition site of platelet glycoprotein IIb-IIIa on nonactivated platelets is accessible to high-affinity macromolecules.
Tomiyama Y; Tsubakio T; Piotrowicz RS; Kurata Y; Loftus JC; Kunicki TJ
Blood; 1992 May; 79(9):2303-12. PubMed ID: 1373972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]